The company remains cashflow negative. Its sale of the MVID business a while back has bolstered cash but you would think they will have to raise more cash some time in the September quarter - imo that's the prospect hanging over the company.
On the plus side they keep kicking goals with positive announcements
However, at an mcap of about $15M (at an SP of 3c, fully diluted, by my calculation) and an annualised ebitda based on the March quarter's figures of about $1.7M the ev/ebitda is around 9 which is probably fair value given the risk of potential dilution in a couple of months time, unfortunately.
Cheers, Sharks,
IVO Price at posting:
2.8¢ Sentiment: Hold Disclosure: Held